← Eichor
Study identifier: NCT03172715 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Prosthesis Versus Osteosynthesis in Proximal Tibia Fractures

Condition: Tibial Fractures  ·  Sponsor: Central Finland Hospital District

PhaseNA
Planned participants98
Who can joinAll sexes, 65 Years to no upper limit
Healthy volunteersNo

About this study

The aim of this study is to compare knee function and pain one year after treatment of intra-articular proximal tibia fracture using either osteosynthesis with a locking plate (ORIF) or primary total knee replacement (TKR) in patients over 65 years of age.

This description comes directly from the study's public registry record.

Talk to the study team

Juha Paloneva, MD, PhD  ·  +358 14 2693119  ·  juha.paloneva@ksshp.fi

Always discuss trial participation with your own doctor first.

Locations (8)

Central Finland HospitalJyväskylä, FinlandRecruiting
Kuopio University HospitalKuopio, FinlandNot Yet Recruiting
Päijät-Häme Central HospitalLahti, FinlandNot Yet Recruiting
Oulu University HospitalOulu, FinlandNot Yet Recruiting
Seinäjoki Central HospitalSeinäjoki, FinlandNot Yet Recruiting
Coxa Joint Replacement HospitalTampere, FinlandNot Yet Recruiting
Tampere University HospitalTampere, FinlandNot Yet Recruiting
Turku University HospitalTurku, FinlandNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03172715